ʻO Rosuvastatin Calcium

ʻO ka wehewehe pōkole:

Ka inoa o ka API Hōʻike Hōʻike US DMF EU DMF CEP
ʻO Rosuvastatin Calcium Hypercholesterolemia I loko o ka Hale/CEP 20705 CEP2015-240


Huahana Huahana

Huahana Huahana

NUI HUA

瑞舒伐他汀钙 ʻO Rosuvastatin Calcium 147098-20-2 I loko o ka Hale/CEP
RSM(Crystal) 147118-40-9 I-Hale
RSM(Kūpono) 147118-40-9 I-Hale
RSP I-Hale
RS-8 147118-36-3 I-Hale
RS-8-1 147118-37-4 I-Hale
TP-8 131466-61-0 I-Hale
TP-11 147118-35-2 I-Hale
TP-13 147118-39-6 I-Hale
RS-10 289042-12-2 I-Hale
RS-11 355806-00-7 I-Hale

wehewehe

ʻO Rosuvastatin Calcium (BANM, JAN, USAN) ʻike ʻia ʻo Rosuvastatin ma US. a me ka mea hoʻokūkū hoʻokūkū HMG-CoA reductase me kahi IC50 o 11 nM[1]. Hoʻopaʻa ikaika ʻo Rosuvastatin Calcium i ke kanaka ether-a-go-go related gene (hERG) i kēia manawa me kahi IC50 o 195 nM, hoʻopaneʻe i ka repolarization cardiac, a no laila e hoʻolōʻihi ai i nā hana hiki ke hana (APDs) a hoʻoponopono i ka wā QT interval (QTc) [2]. Hoʻemi ʻo Rosuvastatin Calcium i ka hōʻike ʻana o ka hERG makua a me ka hoʻopili ʻana o ka protein haʻalulu wela 70 (Hsp70) me ka protein hERG. ʻO Rosuvastatin Calcium ka mea maikaʻi loa i ka hoʻohaʻahaʻa ʻana i ka lipoprotein haʻahaʻa haʻahaʻa (LDL) cholesterol, triglycerides, a me nā pae protein C-reactive [3].

ʻIke hou aʻe e pili ana i nā hui inoa lāʻau: International Nonproprietary Names.

Hoʻolaha Nui: Aia ka ʻikepili honua ʻo Drugs.com ma ka hoʻokuʻu BETA. ʻO ia ke ʻano o ka hoʻomohala ʻia ʻana a loaʻa paha nā hemahema. ʻAʻole i manaʻo ʻia ma ke ʻano he pani no ka ʻike a me ka hoʻoholo ʻana o kāu kauka, lāʻau lapaʻau a i ʻole nā ​​​​mea mālama ola kino ʻē aʻe. ʻAʻole pono e manaʻo ʻia he palekana, kūpono a kūpono paha ka hoʻohana ʻana i kekahi lāʻau lapaʻau ma kekahi ʻāina. E kūkākūkā me kāu kauka mālama ola ma mua o ka lawe ʻana i kekahi lāʻau lapaʻau.

I ka US, ʻo Rosuvastatin (rosuvastatin systemic) he lālā ia o ka papa lāʻau statins a hoʻohana ʻia e mālama i ka Atherosclerosis, High Cholesterol, High Cholesterol - Familial Heterozygous, High Cholesterol - Familial Homozygous, Hyperlipoproteinemia, Hyperlipoproteinemia Type IIa - Elevated LDL, Hyperlipoproteinemia Type. IIb - Hoʻokiʻekiʻe LDL VLDL, Hyperlipoproteinemia Type III - Hoʻokiʻekiʻe beta-VLDL IDL, Hyperlipoproteinemia Type IV - Hoʻokiʻekiʻe VLDL, Hypertriglyceridemia a me ka pale ʻana i ka maʻi cardiovascular.

Kāpae

He mea hoʻokūkū hoʻokūkū hoʻokūkū o HMG-CoA reductase, ʻo ia hoʻi he antilipemic.

 

Waihona

Pauda

-20°C

3 makahiki

4°C

2 makahiki
I ka solvent

-80°C

6 mahina

-20°C

1 mahina

ʻO ke kinona

ʻO Rosuvastatin Calcium

HOOLAHA ANOAI

Hoʻoponopono maikaʻi1

Manaʻo18Nā papahana Loiloi Kūlike Kūlike i ʻae ʻia4, a6apono ʻia nā papahana.

Hoʻoponopono maikaʻi2

Ua hoʻokumu ka ʻōnaehana hoʻokele maikaʻi honua kiʻekiʻe i ke kumu kūʻai.

Hoʻoponopono maikaʻi3

Holo ka nānā ʻana i ka maikaʻi ma ke ola holoʻokoʻa o ka huahana e hōʻoia i ka maikaʻi a me ka hopena therapeutic.

Hoʻoponopono maikaʻi4

Kākoʻo ka hui ʻoihana Regulatory Affairs i nā koi maikaʻi i ka wā o ke noi a me ke kākau inoa ʻana.

HOOLAHA HANA

cpf5
cpf6

Kolea Countec Bottled Packaging Line

cpf7
cpf8

ʻO Taiwan CVC Bottled Packaging Line

cpf9
cpf10

Italia CAM Board Packaging Line

cpf11

Mekini Fette Compacting German

cpf12

ʻO Iapana Viswill Tablet ʻIke

cpf14-1

Keena Mana o DCS

HOA

Ka launa pū ʻana o ka honua
Ka launa pū ʻana o ka honua
ʻO ka launa pū ʻana o ka home
ʻO ka launa pū ʻana o ka home

  • Mua:
  • Aʻe:

  • E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou

    Māhele huahana